NP47827 Multiple Sclerosis Medicines

Pipeline

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Highlights

Deadline
—
Estimated value
£30,403,887
Location
UKM

Details

Published
26 Oct 2026
Deadline
—
Value
£30,403,887
Location
UKM
Source
Find a Tender
Source notice ID
101240-2026
OCID
ocds-h6vhtk-079097
CPV codes
33600000
View on Find a Tender

Description

The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines.

The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape):

Glatiramer acetate

Interferon beta-1a

Teriflunomide

Dimethyl fumarate

Fingolimod

Natalizumab

Cladribine

Similar opportunities

More from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

View all

Lots (3)

LotTitleValue
1Glatiramer acetate, Interferon beta-1a and NatalizumabSupply of Glatiramer acetate, Interferon beta-1a and Natalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.—
2Fingolimod, Teriflunomide and Dimethyl FumarateSupply of Fingolimod, Teriflunomide and Dimethyl Fumarate to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.—
3Cladribine tabletsSupply of cladribine tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.—